Peripheral Vascular Stent Market Size, Share, and Trends Analysis | Global | 2025-2032 | MedCore | Includes: Arterial and Venous Stents

Year: 2026
Scope: 10 Years
Region: Global
Published Date: 12/05/2025
Type: MedCore

Product Description

The global percutaneous transluminal angioplasty balloon market was valued at $558 million in 2025. This is expected to increase over the forecast period at a CAGR of 2.5% to reach nearly $663 million by 2032.

The full report suite on the global market for peripheral vascular stents includes arterial stents and venous stents.

The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

Data Types Included

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
Market Drivers & Limiters
Market Forecasts Until 2032, and Historical Data to 2022
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

Peripheral Vascular Stent Market Trends

An ongoing trend in the peripheral vascular stent market is the growing adoption of drug-eluting stents (DESs) for treating peripheral arterial disease (PAD). These stents are designed to release medication directly at the site of implantation, reducing the risk of restenosis and improving long-term outcomes. The advancement of DES technology has led to improved patency rates and reduced reintervention rates compared to traditional bare-metal stents (BMSs). As clinical evidence continues to support the effectiveness of DESs in peripheral interventions, their adoption is expected to increase, reshaping the landscape of peripheral vascular stent treatments worldwide.

Peripheral Vascular Stent Market Share Insights

W.L. Gore’s strength in the covered stent market comes from the successful development and marketing of its VIABAHN® covered stents. Incremental improvements in the stent, namely a heparin coating and lower profile designs, have paid off. The GORE® TIGRIS® self-expanding vascular stent received Food and Drug Administration (FDA) approval for use in the SFA and proximal popliteal artery (PPA) in 2016.
Boston Scientific holds a strong presence in the iliac and renal stent segments through its Express® LD iliac stent and Express® SD stents. In the venous stenting market, the company is a leading competitor. It leveraged its historical market share with Wallstent™ to successfully introduce the VICI® stent in 2013. With VICI® gaining approval in the U.S. in 2019, Boston Scientific is poised to maintain its robust market positions both domestically and globally in the foreseeable future.
Abbott held the third-leading position in 2025. The company’s Xience Prime™ BTK stent received a CE mark in 2011 and has captured sizable market share within this category. Abbott Vascular sells a wide variety of devices that are both balloon-expandable and self-expandable. Its stents are used in all peripheral indications.

Peripheral Vascular Stent Market Segmentation Summary

Peripheral Vascular Stent Market – Further Segmented Into:
- Device Type: Standard PTA Balloon Catheter, High-Pressure PTA Balloon Catheter, Large PTA Balloon Catheter, Small PTA Balloon Catheter, and Specialty PTA Balloon Catheter.
- Unit Analysis by Application: Central Venous/Hemodialysis Access, Femoral-Popliteal, Iliac, Infra-Popliteal, Renal, Carotid, Aorta, and Others.

Research Scope Summary

Report Attribute	Details
Regions	North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year	2025
Forecast	2026-2032
Historical Data	2022-2024
Quantitative Coverage	Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage	Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources	Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

FREE Sample Report

Peripheral Vascular Stent Market

6.1 Executive Summary

6.1.1 Global Peripheral Vascular Stent Market Overview

6.1.2 Competitive Analysis

6.1.3 Procedures Included

6.1.4 Markets Included

6.1.5 Regions Included

6.2 Introduction

6.2.1 Peripheral Arterial Stents

6.2.1.1 Off-Label Use

6.2.1.2 Covered Stents

6.2.1.3 Drug-Eluting Stents

6.2.1.4 Stent Length

6.2.2 Venous Stents

6.3 Procedure Numbers

6.3.1 Total Peripheral Vascular Stenting Procedures

6.3.2 Arterial Stent Procedures

6.3.2.1 Bare-Metal Stent Procedures

6.3.2.2 Covered Stent Procedures

6.3.2.3 Drug-Eluting Stent Procedures

6.3.3 Venous Stent Procedures

6.4 Market Overview

6.4.1 By Segment

6.4.2 By Region

6.5 Market Analysis and Forecast

6.5.1 Arterial Stent Market

6.5.1.1 Bare-Metal Stent Market

6.5.1.1.1 Bare-Metal Carotid Stent Market

6.5.1.1.2 Bare-Metal Iliac Stent Market

6.5.1.1.3 Bare-Metal Renal Stent Market

6.5.1.1.4 Bare-Metal Fem-Pop Stent Market

6.5.1.1.5 Bare-Metal Infra-Pop Stent Market

6.5.1.2 Covered Stent Market

6.5.1.3 Drug-Eluting Stent Market

6.5.2 Venous Stent Market

6.6 Drivers and Limiters

6.6.1 Market Drivers

6.6.2 Market Limiters

6.7 Competitive Market Share Analysis

Companies Included

W.L. Gore

Boston Scientific

Abbott Vascular

Becton Dickinson

Medtronic

Cook Medical

Cardinal Health

Maquet

Others

Chart List

Chart 6‑1: Peripheral Vascular Stent Market, Global, 2023 & 2030

Chart 6‑2: Peripheral Vascular Stent Procedures, Global, 2023

Chart 6‑3: Peripheral Vascular Stenting Procedures by Region, Global, 2020 – 2030

Chart 6‑4: Peripheral Vascular Stent Market by Segment, Global, 2020 – 2030

Chart 6‑5: Peripheral Vascular Stent Market by Region, Global, 2020 – 2030

Chart 6‑6: Leading Competitors, Peripheral Vascular Stent Market, Global, 2023

Figure List

Figure 6‑1: Peripheral Vascular Stent Procedures Covered

Figure 6‑2: Peripheral Vascular Stent Markets Covered

Figure 6‑3: Peripheral Vascular Stent Regions Covered, Global (1 of 2)

Figure 6‑4: Peripheral Vascular Stent Regions Covered, Global (2 of 2)

Figure 6‑5: Peripheral Vascular Stenting Procedures by Segment, Global, 2020 – 2030

Figure 6‑6: Peripheral Vascular Stenting Procedures by Region, Global, 2020 – 2030

Figure 6‑7: Peripheral Vascular Stenting Procedures by Country, North America, 2020 – 2030

Figure 6‑8: Peripheral Vascular Stenting Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 6‑9: Peripheral Vascular Stenting Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 6‑10: Peripheral Vascular Stenting Procedures by Country, Western Europe, 2020 – 2030

Figure 6‑11: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 6‑12: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 6‑13: Peripheral Vascular Stenting Procedures by Country, Middle East, 2020 – 2030

Figure 6‑14: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 6‑15: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 6‑16: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 6‑17: Peripheral Vascular Stenting Procedures by Country, Africa, 2020 – 2030

Figure 6‑18: Arterial Stent Procedures by Segment, Global, 2020 – 2030

Figure 6‑19: Arterial Stent Procedures by Region, Global, 2020 – 2030

Figure 6‑20: Arterial Stent Procedures by Country, North America, 2020 – 2030

Figure 6‑21: Arterial Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 6‑22: Arterial Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 6‑23: Arterial Stent Procedures by Country, Western Europe, 2020 – 2030

Figure 6‑24: Arterial Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 6‑25: Arterial Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 6‑26: Arterial Stent Procedures by Country, Middle East, 2020 – 2030

Figure 6‑27: Arterial Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 6‑28: Arterial Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 6‑29: Arterial Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 6‑30: Arterial Stent Procedures by Country, Africa, 2020 – 2030

Figure 6‑31: Bare-Metal Stent Procedures by Region, Global, 2020 – 2030

Figure 6‑32: Bare-Metal Stent Procedures by Country, North America, 2020 – 2030

Figure 6‑33: Bare-Metal Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 6‑34: Bare-Metal Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 6‑35: Bare-Metal Stent Procedures by Country, Western Europe, 2020 – 2030

Figure 6‑36: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 6‑37: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 6‑38: Bare-Metal Stent Procedures by Country, Middle East, 2020 – 2030

Figure 6‑39: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 6‑40: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 6‑41: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 6‑42: Bare-Metal Stent Procedures by Country, Africa, 2020 – 2030

Figure 6‑43: Covered Stent Procedures by Region, Global, 2020 – 2030

Figure 6‑44: Covered Stent Procedures by Country, North America, 2020 – 2030

Figure 6‑45: Covered Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 6‑46: Covered Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 6‑47: Covered Stent Procedures by Country, Western Europe, 2020 – 2030

Figure 6‑48: Covered Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 6‑49: Covered Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 6‑50: Covered Stent Procedures by Country, Middle East, 2020 – 2030

Figure 6‑51: Covered Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 6‑52: Covered Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 6‑53: Covered Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 6‑54: Covered Stent Procedures by Country, Africa, 2020 – 2030

Figure 6‑55: Drug-Eluting Stent Procedures by Region, Global, 2020 – 2030

Figure 6‑56: Drug-Eluting Stent Procedures by Country, North America, 2020 – 2030

Figure 6‑57: Drug-Eluting Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 6‑58: Drug-Eluting Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 6‑59: Drug-Eluting Stent Procedures by Country, Western Europe, 2020 – 2030

Figure 6‑60: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 6‑61: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 6‑62: Drug-Eluting Stent Procedures by Country, Middle East, 2020 – 2030

Figure 6‑63: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 6‑64: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 6‑65: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 6‑66: Drug-Eluting Stent Procedures by Country, Africa, 2020 – 2030

Figure 6‑67: Venous Stent Procedures by Region, Global, 2020 – 2030

Figure 6‑68: Venous Stent Procedures by Country, North America, 2020 – 2030

Figure 6‑69: Venous Stent Procedures by Country, Latin America, 2020 – 2030 (1 of 2)

Figure 6‑70: Venous Stent Procedures by Country, Latin America, 2020 – 2030 (2 of 2)

Figure 6‑71: Venous Stent Procedures by Country, Western Europe, 2020 – 2030

Figure 6‑72: Venous Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)

Figure 6‑73: Venous Stent Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)

Figure 6‑74: Venous Stent Procedures by Country, Middle East, 2020 – 2030

Figure 6‑75: Venous Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)

Figure 6‑76: Venous Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)

Figure 6‑77: Venous Stent Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)

Figure 6‑78: Venous Stent Procedures by Country, Africa, 2020 – 2030

Figure 6‑79: Peripheral Vascular Stent Market by Segment, Global, 2020 – 2030 (US$M)

Figure 6‑80: Peripheral Vascular Stent Market by Region, Global, 2020 – 2030 (US$M)

Figure 6‑81: Arterial Stent Market by Segment, Global, 2020 – 2030 (US$M)

Figure 6‑82: Total Arterial Stent Market, Global, 2020 – 2030

Figure 6‑83: Units Sold by Region, Arterial Stent Market, Global, 2020 – 2030

Figure 6‑84: Average Selling Price by Region, Arterial Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑85: Market Value by Region, Arterial Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑86: Bare-Metal Stent Market by Segment, Global, 2020 – 2030 (US$M)

Figure 6‑87: Total Bare-Metal Stent Market, Global, 2020 – 2030

Figure 6‑88: Units Sold by Region, Bare-Metal Stent Market, Global, 2020 – 2030

Figure 6‑89: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑90: Market Value by Region, Bare-Metal Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑91: Bare-Metal Carotid Stent Market, Global, 2020 – 2030

Figure 6‑92: Units Sold by Region, Bare-Metal Carotid Stent Market, Global, 2020 – 2030

Figure 6‑93: Average Selling Price by Region, Bare-Metal Carotid Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑94: Market Value by Region, Bare-Metal Carotid Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑95: Bare-Metal Iliac Stent Market, Global, 2020 – 2030

Figure 6‑96: Units Sold by Region, Bare-Metal Iliac Stent Market, Global, 2020 – 2030

Figure 6‑97: Average Selling Price by Region, Bare-Metal Iliac Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑98: Market Value by Region, Bare-Metal Iliac Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑99: Bare-Metal Renal Stent Market, Global, 2020 – 2030

Figure 6‑100: Units Sold by Region, Bare-Metal Renal Stent Market, Global, 2020 – 2030

Figure 6‑101: Average Selling Price by Region, Bare-Metal Renal Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑102: Market Value by Region, Bare-Metal Renal Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑103: Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030

Figure 6‑104: Units Sold by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030

Figure 6‑105: Average Selling Price by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑106: Market Value by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑107: Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030

Figure 6‑108: Units Sold by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030

Figure 6‑109: Average Selling Price by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑110: Market Value by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑111: Covered Stent Market, Global, 2020 – 2030

Figure 6‑112: Units Sold by Region, Covered Stent Market, Global, 2020 – 2030

Figure 6‑113: Average Selling Price by Region, Covered Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑114: Market Value by Region, Covered Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑115: Drug-Eluting Stent Market, Global, 2020 – 2030

Figure 6‑116: Units Sold by Region, Drug-Eluting Stent Market, Global, 2020 – 2030

Figure 6‑117: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑118: Market Value by Region, Drug-Eluting Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑119: Venous Stent Market, Global, 2020 – 2030

Figure 6‑120: Units Sold by Region, Venous Stent Market, Global, 2020 – 2030

Figure 6‑121: Average Selling Price by Region, Venous Stent Market, Global, 2020 – 2030 (US$)

Figure 6‑122: Market Value by Region, Venous Stent Market, Global, 2020 – 2030 (US$M)

Figure 6‑123: Leading Competitors, Peripheral Vascular Stent Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

Original primary research that consists of the most up-to-date market data
Strong foundation of quantitative and qualitative research
Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Report Options

Report Summary

FREE

Select License Type

Overall, the global peripheral vascular stent market was valued at $2.7 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach $3.3 million.